English | Español
Jamie Barrand | Dec 1, 2015

Synthetic Biologics releases study results for SYN-004
Jamie Barrand | Dec 1, 2015

Study looks at link between pollution, heart disease in diabetic women
Jamie Barrand | Dec 1, 2015

Empliciti approved by FDA for treatment of multiple myeloma
Kerry Goff | Dec 1, 2015

University of Toronto's new ALS research may have pinpointed cause of disease
Jamie Barrand | Nov 26, 2015

Intravenous form of ibuprofen now available in Australia
Jamie Barrand | Nov 25, 2015

CRS-207 designated as orphan drug for mesothelioma treatment
Jamie Barrand | Nov 25, 2015

Opdivo becomes sole PD-1 inhibitor to increase survival rate of renal cell carcinoma patients
Kim Sunderland | Nov 25, 2015

AMA Interaction Studio allows next-gen collaboration between physicians, entrepreneurs

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access